Bettina Malzkuhn
Papers
1
Total Citations
30
H-Index
1
About
Bettina Malzkuhn is a leading clinical researcher in radiation oncology, with a specialized focus on stereotactic body radiation therapy (SBRT) for lung tumors. Her most cited work, a 2018 study on robotic-guided SBRT, evaluated the efficacy and toxicity of gross tumor volume (GTV) mean dose optimization, with and without real-time motion compensation. This research, drawing on data from 208 patients treated between 2011 and 2017, has garnered 30 citations and represents a significant contribution to improving precision in lung cancer treatment. Malzkuhn’s work is particularly notable for advancing the clinical application of robotic motion-compensation technologies, which enhance targeting accuracy for moving tumors. Her findings help refine dose delivery strategies to maximize tumor control while minimizing damage to healthy tissue. By systematically analyzing outcomes for both primary and secondary lung tumors, she has provided valuable evidence for optimizing SBRT protocols. Her research directly impacts clinical decision-making, offering oncologists and medical physicists clearer guidelines for treating complex thoracic malignancies. Malzkuhn’s contributions underscore her role in pushing the boundaries of non-invasive, high-precision radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1